Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Curtin

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2010
Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathologyDaniel Larocque, Nicholas S R Sanderson, Josée Bergeron, et al.
Journal of Virology|December 15, 2005
Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenovirusesWeidong Xiong, Shyam Goverdhana, Sandra A Sciascia, et al.
Journal of Virology|April 9, 2010
A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeuticsMariana Puntel, A K M G Muhammad, Marianela Candolfi, et al.
Plos Medicine|January 16, 2009
HMGB1 mediates endogenous TLR2 activation and brain tumor regressionJames F Curtin, Naiyou Liu, Marianela Candolfi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2009
Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicityMarianela Candolfi, Kader Yagiz, David Foulad, et al.
Neoplasia (New York, N.Y.)|October 27, 2011
B cells are critical to T-cell-mediated antitumor immunity induced by a combined immune-stimulatory/conditionally cytotoxic therapy for glioblastomaMarianela Candolfi, James F Curtin, Kader Yagiz, et al.
European Journal of Medicinal Chemistry|August 13, 2021
Enhanced pyrazolopyrimidinones cytotoxicity against glioblastoma cells activated by ROS-Generating cold atmospheric plasmaZhonglei He, Clara Charleton, Robert W Devine, et al.
Clinical Pharmacology and Therapeutics|February 19, 2010
Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastomaA K M G Muhammad, M Puntel, M Candolfi, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2010
Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathologyDaniel Larocque, Nicholas S R Sanderson, Josée Bergeron, et al.
Journal of Virology|December 15, 2005
Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenovirusesWeidong Xiong, Shyam Goverdhana, Sandra A Sciascia, et al.
Journal of Virology|April 9, 2010
A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeuticsMariana Puntel, A K M G Muhammad, Marianela Candolfi, et al.
Plos Medicine|January 16, 2009
HMGB1 mediates endogenous TLR2 activation and brain tumor regressionJames F Curtin, Naiyou Liu, Marianela Candolfi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2009
Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicityMarianela Candolfi, Kader Yagiz, David Foulad, et al.
Neoplasia (New York, N.Y.)|October 27, 2011
B cells are critical to T-cell-mediated antitumor immunity induced by a combined immune-stimulatory/conditionally cytotoxic therapy for glioblastomaMarianela Candolfi, James F Curtin, Kader Yagiz, et al.
European Journal of Medicinal Chemistry|August 13, 2021
Enhanced pyrazolopyrimidinones cytotoxicity against glioblastoma cells activated by ROS-Generating cold atmospheric plasmaZhonglei He, Clara Charleton, Robert W Devine, et al.
Clinical Pharmacology and Therapeutics|February 19, 2010
Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastomaA K M G Muhammad, M Puntel, M Candolfi, et al.
Pageof 10